Literature DB >> 16286568

The continuing saga of the AT2 receptor: a case of the good, the bad, and the innocuous.

Timothy L Reudelhuber.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16286568     DOI： 10.1161/01.HYP.0000193498.07087.83

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  12 in total

1.  Is there a link between angiotensin receptor blockers and cancer?

Authors:  Frank Enseleit; Frank Ruschitzka
Journal:  Curr Hypertens Rep       Date:  2011-02       Impact factor: 5.369

Review 2.  AT2 receptor activities and pathophysiological implications.

Authors:  Luis C Matavelli; Helmy M Siragy
Journal:  J Cardiovasc Pharmacol       Date:  2015-03       Impact factor: 3.105

Review 3.  The RAAS in the pathogenesis and treatment of diabetic nephropathy.

Authors:  Piero Ruggenenti; Paolo Cravedi; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2010-05-04       Impact factor: 28.314

4.  HIV-associated nephropathy: role of AT2R.

Authors:  Divya Salhan; Ankita Sagar; Dileep Kumar; Rungwasee Rattanavich; Partab Rai; Subani Maheshwari; Madhuri Adabala; Mohammad Husain; Guohua Ding; Ashwani Malhotra; Praveen N Chander; Pravin C Singhal
Journal:  Cell Signal       Date:  2011-11-13       Impact factor: 4.315

5.  Angiotensin II signaling up-regulates the immediate early transcription factor ATF3 in the left but not the right atrium.

Authors:  Tal Hasin; Ofer Elhanani; Zaid Abassi; Tsonwin Hai; Ami Aronheim
Journal:  Basic Res Cardiol       Date:  2010-12-30       Impact factor: 17.165

6.  Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors.

Authors:  Andrea Linares; Leena E Couling; Eduardo J Carrera; Robert C Speth
Journal:  J Vis Exp       Date:  2016-06-07       Impact factor: 1.355

Review 7.  Renin inhibitors: optimal strategy for renal protection.

Authors:  Roland E Schmieder
Journal:  Curr Hypertens Rep       Date:  2007-11       Impact factor: 5.369

Review 8.  Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interaction.

Authors:  Kwang Kon Koh; Seung Hwan Han; Pyung Chun Oh; Eak Kyun Shin; Michael J Quon
Journal:  Atherosclerosis       Date:  2009-09-12       Impact factor: 5.162

9.  Angiotensin II type 1 and 2 receptors and lymphatic vessels modulate lung remodeling and fibrosis in systemic sclerosis and idiopathic pulmonary fibrosis.

Authors:  Edwin Roger Parra; Aline Domingos Pinto Ruppert; Vera Luiza Capelozzi
Journal:  Clinics (Sao Paulo)       Date:  2014-01       Impact factor: 2.365

10.  The Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Diabetes.

Authors:  Raj Padwal; Mu Lin; Dean T Eurich
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-08-19       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.